PACB vs VREX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 14, 2026

PACB

38.3
AI Score
VS
VREX Wins

VREX

46.5
AI Score

Investment Advisor Scores

PACB

38score
Recommendation
AVOID NEW MONEY

VREX

47score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric PACB VREX Winner
Forward P/E 0 20.0803 Tie
PEG Ratio -0.17 6.2987 Tie
Revenue Growth 5.5% 3.7% PACB
Earnings Growth 0.0% 453.4% VREX
Tradestie Score 38.3/100 46.5/100 VREX
Profit Margin -81.3% 2.6% VREX
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD VREX

Relative Price Performance (Last 90 Days)

PACB 1M: +0.0% · 3M: +62.0% VREX 1M: -2.0% · 3M: -2.0%

Current Technical Phase

PACB

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 43

RSI (14): 43.1 · Price: $1.96

VREX

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope 0.5%) with fading momentum, RSI 33

RSI (14): 33.1 · Price: $18.10

Fundamentals Snapshot

Metric PACB VREX
Market Cap — —
Forward P/E -4.9 16.9
Trailing P/E — 34.3
Revenue (TTM) — —
Revenue Growth 0.1% 0.0%
Gross Margin 0.3% 0.3%
Operating Margin -3.3% 0.1%
EPS -0.42 0.53
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, VREX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.